Phase
Condition
Reproductive Health
Polycystic Ovarian Syndrome
Treatment
Aromatase inhibitor Letrozole
Clinical Study ID
Ages 18-35 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age 18-35 years
duration of infertility 1-4 years
PCOS
Exclusion
Exclusion Criteria:
women with other causes of infertility (tubal factor assessed by laparoscopy or hysterosalpingogram, uterine cavity abnormality assessed by ultrasound or hysteroscopy or male factor assessed by seme analysis),
endometriosis,
ovarian cysts,
endocrinological abnormalities (Diabetes mellitus, hypothalamic, pituitary orthyroid disorders, or hyperprolactinemia),
women with history of poor ovarian response or ovarian hyperstimulation
women with chronic diseases, chromosomal, autoimmune or coagulation defects,abnormal leucocytic count or other inflammatory markers
Women with contraindications to pregnancy.
Study Design
Connect with a study center
Kasr Alainy medical school
Cairo, 12111
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.